Literature DB >> 32898930

Accuracy of contralateral Villalta score to assess for pre-existing chronic venous insufficiency in patients with unilateral deep vein thrombosis.

Jean-Philippe Galanaud1, Thierry Ducruet2, Susan R Kahn3.   

Abstract

BACKGROUND: International guidelines recommend using the Villalta score (VS) to diagnose the postthrombotic syndrome (PTS). However, a high proportion of PTS detected with VS could just reflect the presence of preexisting primary venous insufficiency (PVI). Furthermore, it is unclear whether the contralateral VS (cl-VS) can be used to assess for preexisting PVI.
OBJECTIVES: To estimate whether cl-VS can be used to assess for preexisting PVI, and to assess the proportion of PTS that could be attributable to preexisting PVI.
METHODS: Subanalysis of the SOX multicenter randomized trial focusing on patients with a first unilateral proximal deep vein thrombosis (DVT) followed for up to 2 years. PVI was defined as a baseline cl-VS > 4, and PTS as VS > 4 in the leg ipsilateral to DVT starting 6 months after DVT.
RESULTS: Among 680 patients, mean cl-VS remained stable over time: 1.23 (standard deviation [SD] ±2.49) at baseline and 1.17 (±2.20), 1.59 (±2.81), 1.54 (±2.50), 1.65 (±2.82), and 1.55 (±2.63) at the 1-, 6-, 12-, 18-, and 24-month visits, respectively. Baseline cl-VS and ipsilateral VS measured during follow-up were mildly correlated (Pearson correlation = 0.13-0.25). This association disappeared after subtracting the cl-VS measured at the same visit from the ipsilateral VS. Overall, 48.8% of patients developed PTS of whom 12.8% had baseline cl-VS > 4.
CONCLUSION: In our study of patients with a first unilateral proximal DVT, the proportion of patients with PTS who had a cl-VS > 4 is modest. However, cl-VS appears to be stable over time. Its assessment could constitute a simple way of documenting preexisting PVI and help to classify patients as having PTS.
© 2020 International Society on Thrombosis and Haemostasis.

Entities:  

Keywords:  deep vein thrombosis; diagnosis; epidemiology; post-thrombotic syndrome; venous thrombosis

Mesh:

Year:  2020        PMID: 32898930     DOI: 10.1111/jth.15091

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  1 in total

1.  External validation of Villalta score in high-middle income country patients with deep vein thrombosis.

Authors:  Rafael Bernardes de Ávila; Giulianna Barreira Marcondes; Silfayner Victor Mathias Dias; Beatriz Périco da Silveira; Jorge Eduardo de Amorim; Henrique Jorge Guedes Neto; Luis Carlos Uta Nakano; Ronald Luiz Gomes Flumignan
Journal:  Medicine (Baltimore)       Date:  2022-06-17       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.